CD19-BCMA targeted CAR-T therapy

CD19-BCMA CAR-T

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-BCMA targeted CAR-T therapy, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis [Phase 1]